Results 171 to 180 of about 1,007,353 (300)

Vaccine Hesitancy and Acceptance: The Present and the Future

open access: yesVaccines
In the following Special Issue of Vaccines, entitled “Acceptance and Hesitancy in Vaccine Uptake,” seventeen diverse papers examine the critical role of vaccination in health promotion and disease prevention [...]
openaire   +3 more sources

Atypical X‐Linked Severe Combined Immunodeficiency in a Patient With Early‐Onset Inflammatory Bowel Disease

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Primary immunodeficiency disorders may present with gastrointestinal inflammation resembling inflammatory bowel disease (IBD), particularly in patients with pediatric or very‐early‐onset disease. We report a 24‐year‐old male with lifelong immune dysregulation and early‐onset IBD who was ultimately found to carry a hemizygous intronic IL2RG ...
Agustina Fainguersch   +9 more
wiley   +1 more source

Cultural and structural barriers to HPV vaccine acceptance among young women in the United Arab Emirates. [PDF]

open access: yesPLoS One
Langhe R   +8 more
europepmc   +1 more source

Knowledge, Acceptance, and Hesitancy Toward Malaria Vaccination Among Healthcare Providers in Conflict-Affected Sudan: A Cross-Sectional Study

open access: yesInternational Journal of Medical Students
Background: Malaria remains a major public health challenge in Sudan, particularly in regions affected by ongoing armed conflict and displacement.
Raghda M. Babiker   +11 more
doaj  

Vaccine acceptance in a future pandemic after COVID-19 and its decision drivers in Japan. [PDF]

open access: yesNPJ Vaccines
Kawasaki J   +7 more
europepmc   +1 more source

The tRNA‐Modification Geranyl‐2‐Thiouridine Enables RNA‐Lipid Association

open access: yesAngewandte Chemie International Edition, EarlyView.
We report the preparation of mono‐ to tri‐geranylated RNA and the association of the hydrophobic RNA with membranes for future efficient incorporation of RNA into liposomes. ABSTRACT The packaging of RNA in lipid nanoparticles for protection and delivery was key for the development of mRNA vaccines and therapeutics. Formulation requires the addition of
Johannes Singer   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy